[Methohexital clearance in patients with acute hepatitis (author's transl)].
Pharmacokinetics of methohexital were studied in patients with acute hepatitis and after a treatment period either with "essential phospholipids" or phenobarbital. During the acute phase the distribution of methohexital was significantly altered. No change had been observed in the methohexital clearance. During remission the distribution of methohexital was in a normal range. After treatment with phenobarbital the methohexital clearance increased significantly whereas no change was observed after treatment with "essential phospholipids".
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006505:Hepatitis / Q000378:metabolism*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008723:Methohexital / Q000008:administration & dosage / Q000097:blood*; D008875:Middle Aged; D010634:Phenobarbital / Q000494:pharmacology; D010743:Phospholipids / Q000494:pharmacology
D010743:Phospholipids; D008723:Methohexital; D010634:Phenobarbital
Plasmaclearance von Methohexital bei akuter Hepatitis. Einfluss einer Behandlung mit essentiellen Phospholipiden oder Phenobarbital.